Announcements Trials
Browse Landscape Eligibility

Clinical Trials

4 trials
RecentStart dateEnrollment
ESCC × Clear all

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Unknown 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 12991Neoplasms 10383Carcinoma, Non-Small-Cell Lung 6796Prostatic Neoplasms 6198Colorectal Neoplasms 5864Lung Neoplasms 5042Multiple Myeloma 3542Pancreatic Neoplasms 3512Neoplasm Metastasis 3480Leukemia, Myeloid, Acute 3469Carcinoma, Hepatocellular 3232Ovarian Neoplasms 3138Melanoma 3120Stomach Neoplasms 3020Lymphoma 2970Head and Neck Neoplasms 2575Recurrence 2528Precursor Cell Lymphoblastic Leukemia-Lymphoma 2485Leukemia 2353Colonic Neoplasms 2317Brain Neoplasms 2293Lymphoma, Non-Hodgkin 2257Rectal Neoplasms 2173Uterine Cervical Neoplasms 2164Glioblastoma 1993Leukemia, Lymphocytic, Chronic, B-Cell 1985Carcinoma, Renal Cell 1897Squamous Cell Carcinoma of Head and Neck 1857Lymphoma, Follicular 1829Esophageal Neoplasms 1786

Interventions

trifluridine tipiracil drug combination 1camrelizumab 1anlotinib 1Radiotherapy 1Induction Chemotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting
45 enrolled

ESCC

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed
44 enrolled

ESCC

NCT05050760 2023-01-31

DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer

Xijing Hospital

Phase NA Unknown
55 enrolled

ESCC

NCT04471480 2020-07-15

TC

Third Military Medical University

Phase NA Unknown
90 enrolled

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡